Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

26.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

664
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
664

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model.

Nature communications·2026
Same author

Cerebrospinal delivery of a bidirectional AAV9 vector improves optic nerve and retinal pathology in a sheep model of Tay-Sachs disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Overcoming host immune responses to an AAV-delivered HIV-1 bNAb in rhesus macaques mediated by co-delivery of PD-L1.

bioRxiv : the preprint server for biology·2026
Same author

Co-delivered PD-L1 rescues the protective efficacy mediated by an AAV-expressed HIV-1 bNAb.

bioRxiv : the preprint server for biology·2026
Same author

Control of lipid metabolism in chondrocytes is critical for skeletal growth.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

USP24-dependent STAT2 stabilization mediates physiologic and pathologic bone formation.

Cell death & disease·2026

Related Experiment Video

Updated: Nov 18, 2025

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

2.7K

Viral vector platforms within the gene therapy landscape.

Jote T Bulcha1,2, Yi Wang3, Hong Ma1

  • 1Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA.

Signal Transduction and Targeted Therapy
|February 9, 2021
PubMed
Summary
This summary is machine-generated.

Gene therapy, using viral vectors like adenoviruses, adeno-associated viruses, and lentiviruses, offers hope for diseases but faces challenges. Research reviews these key viral vectors for improved treatments.

More Related Videos

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

4.9K
Author Spotlight: Optimizing Digital Droplet PCR Method for Accurate Adeno-Associated Viral Genome Quantification
04:43

Author Spotlight: Optimizing Digital Droplet PCR Method for Accurate Adeno-Associated Viral Genome Quantification

Published on: October 11, 2024

2.5K

Related Experiment Videos

Last Updated: Nov 18, 2025

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

2.7K
Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

4.9K
Author Spotlight: Optimizing Digital Droplet PCR Method for Accurate Adeno-Associated Viral Genome Quantification
04:43

Author Spotlight: Optimizing Digital Droplet PCR Method for Accurate Adeno-Associated Viral Genome Quantification

Published on: October 11, 2024

2.5K

Area of Science:

  • * Gene therapy and viral vector technology.
  • * Translational medicine and drug development.

Background:

  • * Gene therapy has a 40-year history with significant progress and setbacks.
  • * Viral vectors are central to gene therapy, enabling novel drug platforms.
  • * Recent years show increased regulatory approval of viral vector-based gene therapies.

Purpose of the Study:

  • * To review the current landscape of viral vector-based gene therapy.
  • * To focus on three key vector strategies: adenoviruses, adeno-associated viruses, and lentiviruses.
  • * To describe their mechanisms of action and therapeutic roles.

Main Methods:

  • * Review of scientific literature on viral vector-based gene therapy.
  • * Focus on adenovirus, adeno-associated virus, and lentivirus vector platforms.
  • * Analysis of mechanisms of action and clinical applications.

Main Results:

  • * Viral vectors have enabled significant advances in treating human diseases.
  • * Adenoviruses, AAVs, and lentiviruses are leading platforms in preclinical and clinical studies.
  • * Approved gene therapies demonstrate diverse applications from cancer to monogenic diseases.

Conclusions:

  • * Viral vector-based gene therapy holds immense potential for treating various diseases.
  • * Continued research is needed to overcome existing challenges and maximize therapeutic benefits.
  • * Understanding key viral vector platforms is crucial for future gene therapy development.